scholarly journals The Amyloid Precursor Protein regulates human cortical neurogenesis

2021 ◽  
Author(s):  
Khadijeh Shabani ◽  
Julien Pigeon ◽  
Marwan Benaissa Touil Zariouh ◽  
Tengyuan Liu ◽  
Azadeh Saffarian ◽  
...  

AbstractThe human neocortex has undergone significant expansion during evolution partially underlying increased human cognitive capacities. The 16 billion neurons of the human neocortex are derived from a limited number of cortical neural progenitor cells (NPCs). Human cortical NPCs initially generate neurons at a slow rate while preserving their progenitor state for a prolonged period, partly contributing to increased human cortical size. How the balance between the progenitor state and neurogenic state is regulated, and whether it contributes to species-specific brain patterning, is poorly understood. We find that the human Amyloid Precursor Protein (APP), whose mutations cause Alzheimer’s disease, specifically regulates this fine balance. Mechanistically, APP regulates these two aspects via two pathways: the AP1 transcription factor and the canonical Wnt pathway. We propose that APP is a homeostatic regulator of the neurogenic potential of cortical NPCs thus potentially contributing to human-specific patterns of neurogenesis.

1991 ◽  
Vol 12 (5) ◽  
pp. 575-583 ◽  
Author(s):  
J.Steven Jacobsen ◽  
Helen A. Muenkel ◽  
Arthur J. Blume ◽  
Michael P. Vitek

1994 ◽  
Vol 22 (1-4) ◽  
pp. 121-131 ◽  
Author(s):  
W.J. Lukiw ◽  
E.I. Rogaev ◽  
L. Wong ◽  
G. Vaula ◽  
D.R.C. McLachlan ◽  
...  

1993 ◽  
Vol 21 (3) ◽  
pp. 238S-238S ◽  
Author(s):  
CLIVE HOLMES ◽  
MARIE-THERESE WEBSTER ◽  
ANDREW W PROCTER ◽  
PAUL T FRANCIS ◽  
DAVID M BOWEN

2003 ◽  
Vol 70 ◽  
pp. 213-220 ◽  
Author(s):  
Gerald Koelsch ◽  
Robert T. Turner ◽  
Lin Hong ◽  
Arun K. Ghosh ◽  
Jordan Tang

Mempasin 2, a ϐ-secretase, is the membrane-anchored aspartic protease that initiates the cleavage of amyloid precursor protein leading to the production of ϐ-amyloid and the onset of Alzheimer's disease. Thus memapsin 2 is a major therapeutic target for the development of inhibitor drugs for the disease. Many biochemical tools, such as the specificity and crystal structure, have been established and have led to the design of potent and relatively small transition-state inhibitors. Although developing a clinically viable mempasin 2 inhibitor remains challenging, progress to date renders hope that memapsin 2 inhibitors may ultimately be useful for therapeutic reduction of ϐ-amyloid.


2010 ◽  
Vol 34 (8) ◽  
pp. S27-S27
Author(s):  
Jianqi Cui ◽  
Xiuying Pei ◽  
Qian Zhang ◽  
Bassel E. Sawaya ◽  
Xiaohong Lu ◽  
...  

2010 ◽  
Vol 5 (S 01) ◽  
Author(s):  
M Udelhoven ◽  
T Ehlkes ◽  
MM Hettich ◽  
S Asrat ◽  
W Krone ◽  
...  

Acta Naturae ◽  
2011 ◽  
Vol 3 (1) ◽  
pp. 69-76 ◽  
Author(s):  
K D Nadezhdin ◽  
O V Bocharova ◽  
E V Bocharov ◽  
A S Arseniev

Sign in / Sign up

Export Citation Format

Share Document